Cancer Drugs May Help Treatment of Schizophrenia

Researchers have revealed the molecular pathway that is affected during the onset of schizophrenia and successfully alleviated symptoms of the illness in mice, using a commonly used cancer drug.

The research, published online in the journal Brain, is from a group led by Professor Peter Giese at King’s College London, and offers new avenues for drug discovery….

Adapted by ScienceDaily Staff
Reference: O. Engmann, T. Hortobagyi, R. Pidsley, C. Troakes, H.-G. Bernstein, M. R. Kreutz, J. Mill, M. Nikolic, K. P. Giese. Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain, 2011; DOI: 10.1093/brain/awr155

Speak Your Mind